Cargando…
Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma—A Retrospective Single-Institute Study
SIMPLE SUMMARY: Sentinel lymph node (SLN) status is still the most important prognostic factor for melanoma patients; however, the efficacy of completing lymph node dissection remains questionable. The aim of our study was to assess the correlation between known prognostic factors, mutational occurr...
Autores principales: | Liszkay, Gabriella, Mátrai, Zoltán, Czirbesz, Kata, Jani, Nóra, Bencze, Eszter, Kenessey, István |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268142/ https://www.ncbi.nlm.nih.gov/pubmed/34209415 http://dx.doi.org/10.3390/cancers13133302 |
Ejemplares similares
-
Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients
por: Eikenes, Grethe, et al.
Publicado: (2023) -
Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3(+) cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome
por: Mohos, Anita, et al.
Publicado: (2013) -
BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017) -
BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas
por: Manninen, Atte A., et al.
Publicado: (2019) -
Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma
por: Filipović, Nika, et al.
Publicado: (2021)